Tingley Whittemore 4

What Happened Tingley Whittemore, Chief Medical Officer of Tenaya Therapeutics (TNYA), sold 3,121 common shares on May 18, 2026, at $0.79 per share for a total of $2,477. The filing (Form 4) reports this was a sale to satisfy tax withholding obligations related to the vesting of restricted stock units (RSUs).

Key Details

• Transaction date: 2026-05-18; sale price: $0.79/share; shares sold: 3,121; proceeds: ~$2,477. (Transaction code: S)
• Footnote F1: Shares were sold to cover tax withholding on RSUs that vested (award dated January 24, 2025).
• Footnote F2: Reporting person has 112,919 shares of common stock that will be issued upon vesting of RSUs.
• Filing date: 2026-05-19 — the Form 4 was filed the next day and is timely (no late filing noted).

Context This was a tax-withholding sale (routine) tied to RSU vesting rather than a market-driven disposition of an existing stake. Such sales are commonly administrative and do not necessarily signal a change in the insider’s view of the company.